Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Growblox Sciences Inc (OP: GBLX )

0.0540 USD +0.0022 (+4.25%)
Streaming Delayed Price Updated: 12:51 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Growblox Sciences Inc

< Previous 1 2 3 4 5 6 Next >
GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients
GB Sciences, Inc. (OTCQB:GBLX) today announced it has obtained an exclusive license to formulate, manufacture, and sell cannabis-infused oral thin films through its MME-licensed subsidiaries and... 
From PR Newswire
GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies
GBS Global Biopharma's proprietary neuropathic pain therapies are orally-delivered, time-released nanoparticles containing myrcene and other cannabinoid-based ingredients 
From PR Newswire
GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility
Positioned to Increase Revenue by Approximately $5.6 Million 
From PR Newswire
GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center
Increases production and ensures a continuous supply of therapeutic cannabis for Louisiana patients. 
From PR Newswire
Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Tim
GB Sciences, Inc. (OTCQB: GBLX) announced that Dr. Dominick Monaco, GB Sciences' Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference TODAY, April 2, at... 
From PR Newswire
GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients
What consumers see is not what they get: Study finds almost no chemical diversity in Nevada's cannabis varieties 
From PR Newswire
In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility
With over five times the production capacity, main facility will allow for a perpetual harvest cycle, ensuring a continuous supply of therapeutic cannabis for patients throughout Louisiana. 
From PR Newswire
Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility
With over five times the production capacity, main facility will allow for a perpetual harvest cycle, ensuring a continuous supply of therapeutic cannabis for patients throughout Louisiana. 
From PR Newswire
GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc.
GB Sciences, Inc. (OTCQB: GBLX) today launched a global expansion strategy with the formation of GBS Global Biopharma Inc. ("GBS Global"), a cannabinoid medicine company based in Canada. GBS Global... 
From PR Newswire
GB Sciences Supports the Position of LSU AgCenter: Allegations Made by Commissioner Are Untrue
LSU AgCenter issued the following statement on Friday, March 8th. 
From PR Newswire
Rapid Rise of Cannabis Related Tourism Helps Fuel the Market Growth
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Completes Harvest of First Cannabis Crop in Partnership with The Louisiana State University Agricultural Research Center
GB Sciences, Inc. (OTCQB: GBLX) announced the harvest of the first test cannabis crop in the company's nationally-recognized collaboration with Louisiana State University Agricultural Center. 
From PR Newswire
GB Sciences Declares A "Research Revolution" At Its "2018 Innovation In Medical Cannabis Therapies" Symposium
GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first annual, "Innovation in Medical Cannabis Therapies" (IMCT) Symposium, held on Friday, November 9th at the "Keep Memory Alive" Event... 
From PR Newswire
Exploring the Lesser Cannabinoids - The Happy Accident of CBN
The following is from GB Sciences, Inc.'s (OTCQB: GBLX) "The Cannabis Brain Nurse," Meredith Patterson RN, BSN, CRRN: With or without a working knowledge of cannabis, most dispensary consumers have a... 
From PR Newswire
GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars
Additionally, this first crop provides important seeds and genetics for future crops 
From PR Newswire
Dr. Andrea Small-Howard, GB Sciences' Chief Science Officer, Introduces, "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid Derived Pharmaceutical Summit
Dr. Small-Howard will elucidate GB Sciences' Natural Products-Based Approach to Drug Discovery and is a panelist for the "Welcome Panel Session: Bringing Together Industry and Academia". 
From PR Newswire
GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Disea
GB Sciences, Inc. (OTCQB: GBLX) announces on November 19, 2018, the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, on behalf of the Louisiana State... 
From PR Newswire
Data Projects the U.S. to Continue its Global Cannabis Market Dominance
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be Mitigated, and Reversed, by Orally Administered Drugs Targeting a Cellular Cannabinoid Receptor
GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the publication of a research article co-authored by GB Sciences and key collaborators in the peer-reviewed journal Channels, which explains the... 
From PR Newswire
GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles
GB Sciences, Inc. (OTCQB: GBLX) and the Universidad de Sevilla (USE) announce the filing of a provisional patent application on the creation of myrcene-containing nanoparticles for use in the treatment... 
From PR Newswire
More From Meredith Patterson, GB Sciences' Brain Nurse, As She Examines the Workings of CBD
Curious about the medical properties of cannabis, Meredith Patterson RN, BSN, CRRN aka "the brain nurse", provides a "tour guide through the lobes" as she writes a series of popular science cannabis... 
From PR Newswire
GB Sciences Expands into the Oklahoma Medical Cannabis Market
GB Sciences, Inc. (OTCQB: GBLX) is proud to announce that it has signed a binding letter of intent with 4EVERGRN, LLC in Oklahoma. This company has been awarded cultivation, processing and dispensary... 
From PR Newswire
Meredith Patterson, GB Sciences' Brain Nurse, Examines the Workings of CBD
Curious about the medical properties of cannabis, Meredith Patterson RN, BSN, CRRN aka "the brain nurse", provides a "tour guide through the lobes" as she writes a series of popular science cannabis... 
From PR Newswire
GB Sciences Sponsors "2018 Innovation In Medical Cannabis Therapies" Symposium
On November 9th, an international medical cannabis symposium, led by Dr. Andrea Small-Howard, will be held in Las Vegas, NV. 
From PR Newswire
GB Sciences' Brain Nurse Explores the New and Exciting World of Medical Cannabis
Curious about the medical properties of cannabis, Meredith Patterson RN, BSN, CRRN aka "the brain nurse", provides a "tour guide through the lobes" as she writes a series of popular science cannabis... 
From PR Newswire
GB Sciences Harvests the First Hemp Crop in Colorado
Harvesting the first crop, in association with the Colorado Hemp Project, GB Sciences explores hemp as a highly reliable source of hard to find cannabinoids and terpenes for cannabis-based medical... 
From PR Newswire
GB Sciences' CEO John Poss and Chief Science Officer Dr. Andrea Small-Howard Featured at Digital Hollywood's California Cannabis Forum in Los Angeles
Mr. Poss will speak on GB Sciences' collaboration with Native Americans in California; Dr. Small-Howard will discuss research to address specific diseases using cannabinoids. 
From PR Newswire
GB Sciences' Dr. Andrea Small-Howard Presents Results of GB Sciences' Novel Pain Formulation Research at UCLA during CannMed 2018
GB Sciences, Inc. (OTCQB: GBLX) announces that their Chief Science Officer, Dr. Andrea Small-Howard (http://www.cannmedevents.com/andrea-small-howard/), will be presenting the results of GB Sciences'... 
From PR Newswire
North American Spending on Legal Cannabis is Expected to Grow to USD 47 Billion by 2027
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery Examining Cannabis-Based, Disease-Modifying Compounds
GB Sciences, Inc. (OTCQB: GBLX) initiates a new project with the Department of Pharmacognosy and Natural Products Chemistry at the National Kapodistrian University of Athens, Greece. Titled: The... 
From PR Newswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.